Neil A. Miller

Neil A. Miller

Auto-generated profile, based on publicly available information

Neil A. Miller

Center for Pediatric Genomic Medicine, Children’s Mercy Hospital, University of Missouri–Kansas City, Kansas City, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2018 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
AGAndrea Gaedigk
Andrea Gaedigk
KSKatrin Sangkuhl
Katrin Sangkuhl
MWMichelle Whirl‐Carrillo
Michelle Whirl‐Carrillo
GTGreyson P. Twist
Greyson P. Twist
TKTeri E. Klein
Teri E. Klein
TCthe PharmVar Steering Committee
the PharmVar Steering Committee

22 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CCChen-Shan Chin
Chen-Shan Chin
JWJustin Wagner
Justin Wagner
QZQiandong Zeng
Qiandong Zeng
EGErik Garrison
Erik Garrison
SGShilpa Garg
Shilpa Garg
JZJustin M. Zook
Justin M. Zook
Most human genomes are characterized by aligning individual reads to the reference genome, but accurate long reads and linked reads now enable us to construct accurate, phased de novo assemblies. We focus on a medically important, highly variable, 5 million base-pair (bp) region where diploid assembly is particularly useful - the Major Histocompatibility Complex (MHC). Here, we develop a human genome benchmark derived from a diploid assembly for the openly-consented Genome in a Bottle sample HG002. We assemble a single contig for each haplotype, align them to the reference, call phased small and structural variants, and define a small variant benchmark for the MHC, covering 94% of the MHC and 22368 variants smaller than 50 bp, 49% more variants than a mapping-based benchmark. This benchmark reliably identifies errors in mapping-based callsets, and enables performance assessment in regions with much denser, complex variation than regions covered by previous benchmarks.

12 July 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JHJohanna M. Huusko
Johanna M. Huusko
MKMinna K. Karjalainen
Minna K. Karjalainen
BGBritney E. Graham
Britney E. Graham
GZGe Zhang
Ge Zhang
EFEmily G. Farrow
Emily G. Farrow
LMLouis Muglia
Louis Muglia
Preterm birth is a leading cause of morbidity and mortality in infants. Genetic and environmental factors play a role in the susceptibility to preterm birth, but despite many investigations, the genetic basis for preterm birth remain largely unknown. Our objective was to identify rare, possibly damaging, nucleotide variants in mothers from families with recurrent spontaneous preterm births (SPTB). DNA samples from 17 Finnish mothers who delivered at least one infant preterm were subjected to whole exome sequencing. All mothers were of northern Finnish origin and were from seven multiplex families. Additional replication samples of European origin consisted of 93 Danish sister pairs (and two sister triads), all with a history of a preterm delivery. Rare exonic variants (frequency <1%) were analyzed to identify genes and pathways likely to affect SPTB susceptibility. We identified rare, possibly damaging, variants in genes that were common to multiple affected individuals. The glucocorticoid receptor signaling pathway was the most significant (p<1.7e-8) with genes containing these variants in a subgroup of ten Finnish mothers, each having had 2–4 SPTBs. This pathway was replicated among the Danish sister pairs. A gene in this pathway, heat shock protein family A (Hsp70) member 1 like (HSPA1L), contains two likely damaging missense alleles that were found in four different Finnish families. One of the variants (rs34620296) had a higher frequency in cases compared to controls (0.0025 vs. 0.0010, p = 0.002) in a large preterm birth genome-wide association study (GWAS) consisting of mothers of general European ancestry. Sister pairs in replication samples also shared rare, likely damaging HSPA1L variants. Furthermore, in silico analysis predicted an additional phosphorylation site generated by rs34620296 that could potentially affect chaperone activity or HSPA1L protein stability. Finally, in vitro functional experiment showed a link between HSPA1L activity and decidualization. In conclusion, rare, likely damaging, variants in HSPA1L were observed in multiple families with recurrent SPTB. Preterm birth is the leading cause of infant mortality, and prematurity is further associated with serious morbidities in later life. Genetic and environmental risk factors play a role in the susceptibility to preterm birth. Despite numerous studies, the genetic basis for preterm birth remains poorly defined. We investigated the presence of rare, possibly risk associated nucleotide variants in mothers with spontaneous preterm births (SPTB). The first set of mothers with family history of recurrent preterm births was of northern Finnish origin. An additional set of mothers (sister pairs, both giving birth preterm) of European origin was also studied. Whole exome sequencing identified multiple rare, likely damaging HSPA1L variants in several families affected by SPTB, and this gene was associated with the glucocorticoid receptor signaling pathway. Potential involvement of one of the HSPA1L variants in SPTB was further supported by large GWAS dataset. In addition, this variant alters protein post-translational modification potential, and thus may affect protein stability and its function as a chaperone.

5 February 2022 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
AGAndrea Gaedigk
Andrea Gaedigk
EBErin C. Boone
Erin C. Boone
SSSteven E. Scherer
Steven E. Scherer
SLSeung-Been Lee
Seung-Been Lee
INIbrahim Numanagić
Ibrahim Numanagić
LKLisa V. Kalman
Lisa V. Kalman

4 December 2018 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
JYJun J. Yang
Jun J. Yang
MWMichelle Whirl‐Carrillo
Michelle Whirl‐Carrillo
Stuart ScottStuart Scott
Stuart Scott
ATAmy J. Turner
Amy J. Turner
Matthias SchwabMatthias Schwab
Matthias Schwab
AGAndrea Gaedigk
Andrea Gaedigk

1 May 2021 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
LLLisa A. Lansdon
Lisa A. Lansdon
MCMaxime Cadieux-Dion
Maxime Cadieux-Dion
BYByunggil Yoo
Byunggil Yoo
NMNeil Miller
Neil Miller
ACAna S.A. Cohen
Ana S.A. Cohen
MFMidhat Farooqi
Midhat Farooqi